ROSTI partners with IDC to bring innovative medical device design and manufacturing capabilities
SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- A report from Ringiertrade. MedTec China 2025, which took place at the Shanghai World Expo Exhibition & Convention Center (SWEECC) from September 24-26, served as the ideal platform to promote the latest innovations in the production of medical devices. At this exhibition, ROSTI Integrated Manufacturing Solutions (Suzhou) Co., Ltd. (ROSTI) provided visitors with interesting...
Gene Solutions Brings Insights on Advances in MRD and Multi-Omics Technologies to the Singapore Society of Oncology Annual Scientific Meeting 2025
SINGAPORE, Oct. 15, 2025 /PRNewswire/ -- What if cancer care could move from reactive to proactive? At the Singapore Society of Oncology Annual Scientific Meeting 2025 (SSO ASM 2025), Gene Solutions showcased how Molecular Residual Disease (MRD) and AI-powered multi-omics technologies are advancing precision oncology across Asia-Pacific, reinforcing Singapore's role as a hub for innovation and global collaboration. The...
DKSH Reinforces Patient-Centric Commitment with “Patient Purpose Day 2025”, Spotlighting Women’s Health Equity
DKSH Business Unit Healthcare continues bringing patient centricity to life with "Patient Purpose Day 2025". This global initiative, held for the third consecutive year across 12 markets across APAC and Switzerland, reinforces DKSH's dedication to improving patient outcomes. This year, the program focuses on advancing equity in women's health through meaningful community...
PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement
Transaction supports PENTAX Medical's strategic focus on core flexible reusable endoscopy MONTVALE, N.J., Oct. 16, 2025 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, for the acquisition of the C2 CryoBalloon™ technology....
Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline
BEIJING and SHANGHAI and BOSTON, Oct. 15, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) today announced that its subsidiary, Beijing Jacobio Pharmaceuticals Co., Ltd. ("Beijing Jacobio"), has entered into a Capital Increase and Equity Transfer Agreement with Oceanpine Capital and an industry partner. Under the agreement, Oceanpine Capital will acquire 80% equity interest in Beijing Jacoray Pharmaceutical Technology Co., Ltd....
CJ BIO Showcases Science-Backed Nutrition Solutions at SSG 2025
DOWNERS GROVE, Ill., Oct. 15, 2025 /PRNewswire/ -- CJ BIO, a global leader in functional health and nutrition solutions, will join SupplySide Global 2025 under the theme "Where Function Meets Clinical Proof." The company will present science-backed Nutrition Solutions for muscle health, beauty, and general wellness, supported by study data and research...
NYSE Content Advisory: Pre-Market Update + Embraer celebrates 25th listing anniversary
NEW YORK, Oct. 15, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE_Market_Update_Oct_15 Ashley Mastronardi delivers the pre-market update on October 15th...
GROWNSY Wraps Up October Prime Day with Strong Performance, Reinforcing Its Commitment to Smart Parenting
NEW YORK, Oct. 15, 2025 /PRNewswire/ -- GROWNSY, a fast-growing baby care brand trusted by parents across the U.S., concluded Amazon's October Prime Day with strong performance and outstanding recognition across key baby product categories. Three of its flagship products—Baby Nasal Aspirator, Baby Bottle Warmer with Timer, and Baby Food Maker—earned Amazon Best Seller badges in their respective categories:#1...
TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals. CAMBRIDGE, Mass., Oct. 15, 2025 /PRNewswire/ -- TriNetX, driven by its vision of a connected world where data and intelligence power improved human health, has become the most cited electronic health...
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia
Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses Phase 1/2 study to enroll ~500 healthy adults, with topline results expected by 2028 We aim to build a universal Sarbecovirus vaccine platform to proactively address future pandemics SEONGNAM, South Korea, Oct. 15, 2025 /PRNewswire/ -- SK bioscience announced that it...
